BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 8, 2017
Distillery Therapeutics

Autoimmune disease; inflammation

BioCentury | May 12, 2014
Strategy

Build up to break up

Why Pfizer needs AstraZeneca to make a break-up plan work
BioCentury | Nov 5, 2012
Clinical News

Brodalumab: Phase III started

BioCentury | Apr 2, 2012
Clinical News

Brodalumab: Phase II data

BioCentury | Mar 29, 2012
Clinical News

Amgen's anti-IL-17R mAb meets psoriasis endpoint

Items per page:
1 - 6 of 6